DALT
Diallyltryptamine (DALT), also known as N,N-diallyltryptamine, is a tryptamine derivative which has been identified as a designer drug.
≈ 18 min read
DALT. encyclopegia.org, snapshot enwiki-001363809128. /a/dalt
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Diallyltryptamine (DALT), also known as N,N-diallyltryptamine, is a tryptamine derivative which has been identified as a designer drug.[2][3]
Use and effects
edit edit sourceAccording to Alexander Shulgin in his book TiHKAL (Tryptamines I Have Known and Loved), the dose of DALT is greater than 40 mg orally and its duration is unknown.[1] Its effects were not described.[1] Per Stephen Szara and colleagues in much earlier publications however, DALT and other extended N,N-dialkyltryptamines produce similar effects to dimethyltryptamine (DMT) but are longer-lasting, with durations of up to 3 hours.[1][4][5]
Interactions
edit edit sourcePharmacology
edit edit sourcePharmacodynamics
edit edit source| Target | Affinity (Ki, nM) |
|---|---|
| 5-HT1A | 100 |
| 5-HT1B | >10,000 |
| 5-HT1D | 689 |
| 5-HT1E | 378 |
| 5-HT1F | ND |
| 5-HT2A | 701 |
| 5-HT2B | 61 |
| 5-HT2C | 385 |
| 5-HT3 | >10,000 |
| 5-HT4 | ND |
| 5-HT5A | >10,000 |
| 5-HT6 | 1,718 |
| 5-HT7 | >10,000 |
| α1A | 1,663 |
| α1B | 1,369 |
| α1D | >10,000 |
| α2A | 124 |
| α2B | 305 |
| α2C | 901 |
| β1–β3 | >10,000 |
| D1, D2 | >10,000 |
| D3 | 672 |
| D4, D5 | >10,000 |
| H1 | 127 |
| H2–H4 | >10,000 |
| M1–M5 | >10,000 |
| I1 | ND |
| σ1 | 101 (rat) |
| σ2 | 356 (rat) |
| TAAR1Tooltip Trace amine-associated receptor 1 | ND |
| MORTooltip μ-Opioid receptor, DORTooltip δ-Opioid receptor | >10,000 |
| KORTooltip κ-Opioid receptor | 2,477 |
| SERTTooltip Serotonin transporter | 150 (Ki) |
| NETTooltip Norepinephrine transporter | 1,121 (Ki) |
| DATTooltip Dopamine transporter | 1,406 (Ki) |
| Notes: The smaller the value, the more avidly the drug binds to the site. All proteins are human unless otherwise specified. Refs:[6][7][8][9] | |
The receptor interactions of DALT have been studied.[6][7][8][9] The drug produces the head-twitch response, a behavioral proxy of psychedelic effects, in rodents.[10]
Chemistry
edit edit sourceDALT has been used as an intermediate in the preparation of radiolabeled diethyltryptamine (DET).[11]
Synthesis
edit edit sourceThe chemical synthesis of DALT has been described.[1]
Analogues
edit edit sourceAnalogues of DALT include 4-HO-DALT, 4-AcO-DALT, 5-MeO-DALT, methylallyltryptamine (MALT), propylallyltryptamine (PALT), and isopropylallyltryptamine (iPALT), among others.[1]
History
edit edit sourceDALT was first described in the scientific literature by Stephen Szara and colleagues by 1962.[4][5]
Society and culture
edit edit sourceLegal status
edit edit sourceCanada
edit edit sourceDALT is not an explicitly nor implicitly controlled substance in Canada as of 2025.[12]
United States
edit edit sourceDALT is not an explicitly controlled substance in the United States.[13] However, it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption.
See also
edit edit sourceReferences
edit edit source- ^ a b c d e f Shulgin A, Shulgin A (September 1997). TiHKAL: The Continuation. Berkeley, California: Transform Press. ISBN 0-9630096-9-9. OCLC 38503252. Wikipedia revision 1363809128, retrieved 2026-11-18
- ^ Michely JA, Helfer AG, Brandt SD, Meyer MR, Maurer HH (October 2015). "Metabolism of the new psychoactive substances N,N-diallyltryptamine (DALT) and 5-methoxy-DALT and their detectability in urine by GC-MS, LC-MSn, and LC-HR-MS-MS" (PDF). Analytical and Bioanalytical Chemistry. 407 (25): 7831–42. doi:10.1007/s00216-015-8955-0. PMID 26297461. S2CID 26086597. Wikipedia revision 1363809128, retrieved 2026-11-18
- ^ Michely JA, Brandt SD, Meyer MR, Maurer HH (February 2017). "n, and LC-HR-MS/MS" (PDF). Analytical and Bioanalytical Chemistry. 409 (6): 1681–1695. doi:10.1007/s00216-016-0117-5. PMID 27933361. S2CID 206920201. Wikipedia revision 1363809128, retrieved 2026-11-18
- ^ a b Brimblecombe RW, Pinder RM (1975). "Indolealkylamines and Related Compounds". Hallucinogenic Agents. Bristol: Wright-Scientechnica. pp. 98–144. ISBN 978-0-85608-011-1. OCLC 2176880. OL 4850660M. Other N,N-dialkyltryptamines produce similar effects to DMT in man, though their persistence is somewhat greater, with hallucinations lasting for up to 3 hours (Szara and Hearst, 1962). These include the N,N-diethyl (DET, 4.8), N,N-dipropyl (4.9), and N,N-diallyl (4.10) compounds, none of which are found in nature. Wikipedia revision 1363809128, retrieved 2026-11-18
- ^ a b Szara S, Hearst E (1962). "The 6-Hydroxylation of Tryptamine Derivatives: A Way of Producing Psychoactive Metabolites". Annals of the New York Academy of Sciences. 96 (1): 134–141. Bibcode:1962NYASA..96..134S. doi:10.1111/j.1749-6632.1962.tb50108.x. The dipropyl and diallyl derivatives have similar hallucinogenic activity in man, as we found recently. Wikipedia revision 1363809128, retrieved 2026-11-18
- ^ a b "Kᵢ Database". PDSP. 28 March 2025. Retrieved 28 March 2025. Wikipedia revision 1363809128, retrieved 2026-11-18
- ^ a b Liu T (2016). "BindingDB BDBM50140058 CHEMBL3752576". Bioorganic & Medicinal Chemistry Letters. 26 (3): 959–964. doi:10.1016/j.bmcl.2015.12.053. PMID 26739781. Retrieved 28 March 2025. Wikipedia revision 1363809128, retrieved 2026-11-18
- ^ a b Cozzi NV, Daley PF (February 2016). "Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines" (PDF). Bioorganic & Medicinal Chemistry Letters. 26 (3): 959–964. doi:10.1016/j.bmcl.2015.12.053. PMID 26739781. Wikipedia revision 1363809128, retrieved 2026-11-18
- ^ a b Klein LM, Cozzi NV, Daley PF, Brandt SD, Halberstadt AL (November 2018). "Receptor binding profiles and behavioral pharmacology of ring-substituted N,N-diallyltryptamine analogs" (PDF). Neuropharmacology. 142: 231–239. doi:10.1016/j.neuropharm.2018.02.028. PMC 6230509. PMID 29499272. Wikipedia revision 1363809128, retrieved 2026-11-18
- ^ Halberstadt AL, Geyer MA (2018). "Effect of Hallucinogens on Unconditioned Behavior". Behavioral Neurobiology of Psychedelic Drugs. Curr Top Behav Neurosci. Vol. 36. pp. 159–199. doi:10.1007/7854_2016_466. ISBN 978-3-662-55878-2. PMC 5787039. PMID 28224459. The HTR has also been observed in rodents treated with N-methyl-N-ethyltryptamine (MET), N,N-diethyltryptamine (DET), N,N-dipropyltryptamine (DPT), N,N-diisopropyltryptamine (DIPT), and N,N-diallyltryptamine (DALT) (Fantegrossi et al. 2008; Smith et al. 2014; Carbonaro et al. 2015; Halberstadt and Klein, unpublished observations). Wikipedia revision 1363809128, retrieved 2026-11-18
- ^ Brandt SD, Tirunarayanapuram SS, Freeman S, Dempster N, Barker SA, Daley PF, et al. (2008). "Microwave-accelerated synthesis of psychoactive deuterated N,N-dialkylated-[α,α,β,β-d4]-tryptamines". Journal of Labelled Compounds and Radiopharmaceuticals. 51 (14): 423–429. doi:10.1002/jlcr.1557. Wikipedia revision 1363809128, retrieved 2026-11-18
- ^ "Controlled Drugs and Substances Act". Department of Justice Canada. 5 December 2025. Retrieved 20 January 2026. Wikipedia revision 1363809128, retrieved 2026-11-18
- ^ Orange Book: List of Controlled Substances and Regulated Chemicals (January 2026) (PDF), United States: U.S. Department of Justice: Drug Enforcement Administration (DEA): Diversion Control Division, January 2026 Wikipedia revision 1363809128, retrieved 2026-11-18
External links
edit edit source- DALT - Isomer Design
- The Big & Dandy DALT (N,N-Diallyltryptamine) Thread - Bluelight
- DALT - TiHKAL - Isomer Design
- No substitutions: Ergine (LSA, LA-111)
- Isoergine (iso-LSA, iso-LA)
- Amide-substituted lysergamides: DAL
- DAM (DAM-57)
- DiPLA
- DPL
- EcPLA
- EiPLA
- EPLA (LEP; LEP-57)
- Ergometrine (ergonovine, ergobasine)
- ETFELA
- iPLA
- LA-3Cl-SB (Cl-LSB)
- LAE (LAE-32)
- LAM
- LAMPA
- LAP
- LME (LME-54)
- LMP (LMP-55)
- LPD (LPD-824)
- LSB
- LSD (LSD-25, METH-LAD; lysergide)
- LSD-Pip
- LSDP (DPL)
- LSH (LAH)
- LSM (LSM-775)
- 2-LSP
- LSP (3-LSP)
- LSZ (LA-SS-Az)
- Lysergic acid pyrrolinide (LPN)
- Methylergometrine (methylergonovine, methylergobasine)
- MiPLA
- TRALA-12 (didehydro-LSD; DDH-LSD)
- 6-Alkyllysergamides: BU-LAD
- CE-LAD (CHLORETH-LAD)
- CPM-LAD
- CYP-LAD (TRALA-22)
- ETH-LAD
- FLUORETH-LAD (FE-LAD)
- FP-LAD
- IP-LAD
- NBOMe-LAD
- PARGY-LAD
- PRO-LAD
- 1-Alkyllysergamides (prodrugs): Methysergide (1-methylmethylergonovine; UML-491)
- MLA-74 (1-methyl-LAE)
- MLD-41 (1-methyl-LSD)
- MPD-75 (1-methyl-LPD)
- OML-632 (1-hydroxymethyl-LSD)
- 1-Acyllysergamides (prodrugs): 1-Formyl-LSD
- 1B-LSD
- 1BP-LSD
- 1Bz-LSD
- 1cP-AL-LAD
- 1cP-LSD
- 1cP-MiPLA
- 1D-AL-LAD
- 1D-LSD
- 1DD-LSD
- 1F-LSD
- 1Fe-LSD
- 1H-LSD
- 1P-AL-LAD
- 1P-ETH-LAD
- 1P-LSD
- 1P-MiPLA
- 1S-LSD
- 1SB-LSD (1BS-LSD; 1-TMSBz-LSD)
- 1T-AL-LAD
- 1T-LSD
- 1V-LSD
- ALA-10 (1-acetyl-LAE; 1A-LAE)
- ALD-52 (1-acetyl-LSD; 1A-LSD)
- Bioisosteres: JRT (isotryptamine-LSD)
- 9-Oxaergolines (e.g., RU-29717)
- γ-Carbolines (e.g., tiflucarbine)
- Arylpiperazines (e.g., 2C-B-PP, 2-NP, mCPP, MK-212, ORG-12962, pCPP, pFPP, quipazine, TFMPP, VCU-1012)
- Dihydrobenzoxazines (e.g., efavirenz)
- Ergolines (e.g., pergolide)
- Phenoxyethylamines (e.g., CT-4719, ORG-37684)
- Pyridopyrroloquinoxalines (e.g., IHCH-7113)
- Quinazolinylethylamines (e.g., RH-34)
- Tryptamines: Acacia spp. (e.g., Acacia acuminata, Acacia confusa)
- Ayahuasca and vinho de Jurema (e.g., Psychotria viridis (chacruna), Dipolopterys cabrerana (chaliponga, chacruna), Mimosa tenuiflora (Mimosa hostilis; jurema))
- Brosimum (e.g., Brosimum acutifolium (takini))
- Hallucinogenic snuffs (e.g., Anadenanthera peregrina (yopo, jopo, cohoba, parica, ebene), Anadenanthera colubrina (vilca, cebil))
- Incilius alvarius (Bufo alvarius; Colorado River toad, Sonoran Desert toad; bufo)
- Psilocybin-containing mushrooms (magic mushrooms, shrooms) (e.g., Psilocybe cubensis, Psilocybe mexicana (teonanacatl))
- Phenethylamines: Echinopsis cacti (e.g., San Pedro, Peruvian torch)
- Pachycereus cacti (e.g., Pachycereus pecten-aboriginum, Pachycereus pringlei)
- Peyote (Lophophora williamsii; peyotl)
- Lysergamides: Achnatherum robustum (sleepy grass)
- Epichloë spp.
- Ergot (Claviceps) (e.g., Claviceps purpurea, Claviceps paspali)
- Morning glory (Convolvulaceae) seeds (e.g., Ipomoea tricolor (tlitliltzin, badoh negro; Ipomoea violacea), Ipomoea corymbosa (coaxihuitl, ololiúqui; Rivea Corymbosa, Turbina Corymbosa), Argyreia nervosa (Hawaiian baby woodrose; HBWR))
- Periglandula spp. (e.g., Periglandula ipomoeae, Periglandula clandestina)
- 1-Benzoyl-DMT
- 1-Methyl-DMT (1,N,N-TMT, 1-TMT)
- 1-Methyl-T
- 2-HO-NMT
- 2-Methyl-DET
- 2-Methyl-DiPT
- 2-Methyl-iPALT (ASR-3002)
- 2,N,N-TMT (2-methyl-DMT)
- 3-IAAR
- 4-Bromo-DMT
- 4-Fluoro-DMT
- 4-Fluoro-T
- 4-MeS-DMT
- 4-Methyl-DMT
- 5-Bromo-DMT
- 5-Bromo-T
- 5-Chloro-DMT
- 5-Chloro-T
- 5-CT
- 5-Ethyl-DMT
- 5-Fluoro-DET
- 5-Fluoro-DMT
- 5-Fluoro-EPT
- 5-Fluoro-NiPT
- 5-Fluoro-T
- 5-Me-MiPT
- 5-MeS-DMT
- 5-Methyl-DMT
- 5-Methyl-T
- 5-Nitro-T (Nitro-I)
- 6-Fluoro-DET
- 6-Fluoro-DMT
- 6-Fluoro-T
- 6-HO-DET
- 6-HO-DMT
- 6-HO-T (6-HT)
- 6-MeO-DMT
- 6-MeO-T
- 6-Methyl-DMT
- 6-Methyl-T
- 6,7-DHT
- 7-Chloro-T
- 7-Fluoro-T
- 7-HO-DMT
- 7-HO-T (7-HT)
- 7-MeO-DMT
- 7-MeO-T
- 7-Methyl-DMT
- 7-Methyl-T
- 7-Hydroxytryptophan
- Acetryptine (5-AT)
- AHR-1229
- Almotriptan
- Benzotript (4-CB-Trp)
- BGE
- Bretisilocin (5-fluoro-MET; GM-2505)
- Convolutindole A (2,4,6-TBr,1,7-DiMeO-DMT)
- CPI-CG-8
- DALT
- DAT
- DBT
- Desformylflustrabromine
- DET (T-9)
- DMT-d10 (HLP004; CYB004)
- DHT
- DiPT
- DMT
- DPT
- E-6801
- E-6837
- EB-003
- EiPT
- EPT
- FGIN-127
- FGIN-143
- GR-46611
- HBL20016 (5-MeS-6-F-DMT)
- HBL20017 (4-F-5-MeS-DMT)
- Idalopirdine
- iPALT (ALiPT; ASR-3003)
- Lespedamine (1-MeO-DMT)
- L-694247
- MBT
- McPT
- MET
- MiPT
- MPT
- MsBT
- N-Benzyltryptamine (T-NB, NB-T, NBnT)
- N-(2-Cyanoethyl)tryptamine (CE-T)
- N-DEAOP-NET
- N-DEAOP-NMT
- N-Phosphonooxymethyl-DMT (N-POM-DMT)
- NAT
- NBoc-DMT (NB-DMT)
- NcPT
- NET/NETP
- NPT
- NHT
- NiPT
- NMT
- NsBT
- NtBT
- PALT (ASR-3004)
- PiPT
- Rizatriptan
- ST-1936 (2-Me-5-Cl-DMT)
- Sumatriptan
- T-NBOMe
- TCS-1205
- Tryptamine (T; indolylethylamine)
- Tryptophan (Trp)
- WAY-181187
- Yuremamine
- Z2876442907
- ZCZ-011
- Zolmitriptan
and esters/ethers
- 1-Methylpsilocin (CMY-16)
- 4-AcO-DALT
- 4-AcO-DET (ethacetin, ethylacybin)
- 4-AcO-DiPT (ipracetin)
- 4-AcO-DMT (psilacetin; O-acetylpsilocin)
- 4-AcO-DPT (depracetin)
- 4-AcO-EiPT (ethipracetin)
- 4-AcO-EPT
- 4-AcO-MALT
- 4-AcO-McPT
- 4-AcO-MET (metacetin)
- 4-AcO-MiPT (mipracetin)
- 4-AcO-MPT
- 4-AcO-NMT
- 4-AcO-TMT
- 4-HO-5-MeO-T
- 4-HO-DALT (daltocin)
- 4-HO-DBT
- 4-HO-DET (ethocin; CZ-74)
- 4-HO-DiBT
- 4-HO-DiPT (iprocin)
- 4-HO-DPT (deprocin)
- 4-HO-DsBT
- 4-HO-EiBT (eibucin)
- 4-HO-EiPT
- 4-HO-EPT (eprocin)
- 4-HO-MALT (maltocin)
- 4-HO-MET (metocin)
- 4-HO-McPT
- 4-HO-McPeT
- 4-HO-MiPT (miprocin)
- 4-HO-MPT (meprocin)
- 4-HO-MsBT
- 4-HO-NALT
- 4-HO-NBnT
- 4-HO-NcHT
- 4-HO-NET
- 4-HO-NiPT
- 4-HO-NBT (4-HO-NnBT)
- 4-HO-NPT
- 4-HO-NtBT
- 4-HO-PiPT (piprocin)
- 4-HO-TMT
- 4-HT (dinorpsilocin)
- 4-MeO-DET
- 4-MeO-DiPT
- 4-MeO-DMT
- 4-MeO-MiPT
- 4-MeO-T
- 4-PrO-DiPT
- 4-PrO-DMT
- 4-PrO-MET
- 4,5-DHT
- 4,5-MDO-DMT
- 4,5-MDO-DiPT
- Aeruginascin (4-PO-TMT)
- Baeocystin (4-PO-NMT)
- Deupsilocin (HLP003; CYB003)
- EB-002 (EB-373)
- Ethocybin (4-PO-DET; CEY-19)
- Luvesilocin (4-GO-DiPT; RE-104; FT-104)
- MSP-1014
- Norbaeocystin (4-PO-T)
- Norpsilocin (4-HO-NMT)
- O-4310 (1-iPrO-6-F-psilocin)
- Psilocin (4-HO-DMT; CX-59)
- Psilocybin (4-PO-DMT; CY-39)
- Psilomethoxin (4-HO-5-MeO-DMT)
- Psilomethoxybin (4-PO-5-MeO-DMT)
- RE-109 (4-GO-DMT)
5-methoxytryptamines
- 1-Acetyl-5-MeO-DMT
- 2-Methyl-5-HT
- 2-Methyl-5-MeO-DALT
- 4-HO-5-MeO-T
- 4-F-5-MeO-DMT
- 4,5-DHP-DMT
- 4,5-DHT
- 4,5-MDO-DMT
- 4,5-MDO-DiPT
- 5-BT
- 5-Ethoxy-DMT
- 5-HO-DET
- 5-HO-DiPT
- 5-HO-DPT
- 5-HO-MET
- 5-HO-NiPT
- 5-HTP (oxitriptan)
- 5-MeO-2-TMT
- 5-MeO-34MPEMT
- 5-MeO-7,N,N-TMT
- 5-MeO-DALT
- 5-MeO-DBT
- 5-MeO-DET
- 5-MeO-DiPT
- 5-MeO-DMT (N,N,O-TMS; O-methylbufotenine)
- 5-MeO-DPT
- 5-MeO-EiPT
- 5-MeO-EPT
- 5-MeO-MALT
- 5-MeO-MBT
- 5-MeO-MET
- 5-MeO-MiPT
- 5-MeO-MsBT
- 5-MeO-NET
- 5-MeO-NiPT
- 5-MeO-NMT (O,N-DMS)
- 5-MeO-NsBT
- 5-MeO-PiPT
- 5-MeO-NBpBrT
- 5-MeO-T (5-MT; mexamine; O-methylserotonin)
- 5-MeO-T-NBOMe
- 5-MeO-T-NB3OMe
- 5-MTP (cytoguardin)
- 5-NOT
- 5-PhO-T (OVT2)
- 5,6-DHT
- 5,6-DiMeO-DiPT (5,6-MeO-DiPT)
- 5,6-MDO-DiPT
- 5,6-MDO-DMT
- 5,6-MDO-MiPT
- 5,6-MeO-MiPT
- 5,7-DHT
- Arachidonoyl serotonin
- ASR-3001 (5-MeO-iPALT)
- BAB
- Benanserin (BAS; SQ-4788)
- BGC20-761
- Bufotenidine (5-HTQ; N,N,N-TMS)
- Bufotenin (5-HO-DMT; N,N-DMS; mappine)
- Bufoviridine (5-SO-DMT)
- CP-132,484
- Cqd 280
- Cqd 285
- Cqdd 280
- Donitriptan
- EMDT (2-Et-5-MeO-DMT)
- HIOC
- Indorenate (TR-3369)
- IS-159
- Isamide (N-CA-5-MT)
- L-741604
- MS-245
- N-DEAOP-5-MeO-NET
- N-DEAOP-5-MeO-NMT
- N-Feruloylserotonin (moschamine)
- NB-5-MeO-DALT
- NB-5-MeO-DMT
- NB-5-MeO-MiPT
- Norbufotenin (5-HO-NMT; NMS)
- O-Acetylbufotenine (5-AcO-DMT)
- O-Pivalylbufotenine (5-t-BuCO-DMT)
- Psilomethoxin (4-HO-5-MeO-DMT)
- Psilomethoxybin (4-PO-5-MeO-DMT)
- Serotonin (5-HT)
- 2-Iodomelatonin
- 2-Phenylmelatonin
- 5-Methoxyluzindole
- 6-Chloromelatonin
- 6-Fluoromelatonin
- 6-Hydroxymelatonin
- 6-Methoxymelatonin
- 6,7-Dichloro-2-methylmelatonin
- α-Methylmelatonin
- Luzindole
- Melatonin (N-Ac-O-Me-serotonin; N-Ac-5-MeO-T)
- Normelatonin (N-acetylserotonin; NAS)
- N-Acetyltryptamine
- N-Butanoylmelatonin
- N-Propionylmelatonin
- Piromelatine
- TIK-301 (LY-156735)
- 1-Methyl-AMT
- 2,α-DMT (2-Me-AMT)
- 4-HO-αET
- 4-HO-αMT (MP-14)
- 4-Methyl-αET
- 4-Methyl-αMT (MP-809)
- 5-Chloro-αET (PAL-526)
- 5-Chloro-αMT (PAL-542)
- 5-Fluoro-αET (PAL-545)
- 5-Fluoro-αMT (PAL-212; PAL-544)
- 5-Methyl-αET
- 6-Fluoro-αMT
- 7-Chloro-αMT
- 7-Me-αET
- α-Methyltryptophan (αMTP)
- α,N-DMT (N-Me-αMT; SKF-7024, Ro 3-1715)
- α,N,N-TMT (α-Me-DMT; Alpha-N)
- αET (etryptamine; Monase)
- αMT (Indopan; IT-290; 3-API; 3-IT)
- IPAP (α,N-DPT)
- N-Hydroxy-AMT
- Soclenicant (BNC-210; Ile–Trp)
- 5-Hydroxy- and 5-alkoxy-α-alkyltryptamines: 1-Pr-5-MeO-AMT
- 5-Allyloxy-AMT
- 5-Ethoxy-αMT
- 5-iPrO-αMT
- 5-MeO-αET
- 5-MeO-αMT (α,O-DMS; Alpha-O)
- α-Methyl-5-HTP
- α-Methylmelatonin
- α-Methylserotonin (5-HO-αMT; α-Me-5-HT)
- α,N,O-TMS (5-MeO-α,N-DMT)
- α,N,N,O-TeMS (5-MeO-α,N,N-TMT)
- AL-37350A (4,5-DHP-αMT)
- BW-723C86
- β-Keto-α-alkyltryptamines: BK-5Br-NM-AMT
- BK-5Cl-NM-AMT
- BK-5F-NM-AMT
- BK-NM-AMT
- 3-AMTBI
- 5-MeO-IsoqT
- Barettin
- BML-190 (indomethacin morpholinylamide)
- Cyclic 3-OHM
- Ergolines and lysergamides (e.g., LSD)
- Harmala alkaloids and β-carbolines (e.g., 5-methoxyharmalan, norharmine 6-MeO-THH, 6-methoxyharmalan, 9-Me-BC, β-carboline (norharman), fenharmane, harmaline, harmalol, harmane, harmine, LY-266,097, pinoline, tetrahydroharmine, tryptoline)
- Iboga alkaloids (e.g., ibogaine, ibogamine, noribogaine, tabernanthine)
- Ibogalogs (e.g., catharanthalog, fluorogainalog, ibogainalog, ibogaminalog (DM-506), LS-22925, noribogainalog, noribogaminalog, PHA-57378, Pharm-136, PNU-22394, tabernanthalog)
- Imidazolylindoles (e.g., AGH-107, AGH-192, AH-494)
- Metralindole
- Morpholinylethylindoles (e.g., mor-T, 5-MeO-mor-T)
- Partial ergolines and lysergamides (e.g., NDTDI, RU-27849, RU-28251, RU-28306, FHATHBIN, LY-178210, LY-301317, Bay R 1531 (LY-197206), LY-293284, 10,11-seco-LSD, 10,11-secoergoline (α,N-Pip-T), CT-5252)
- Pertines (e.g., alpertine, milipertine, oxypertine, solypertine)
- Piperidinylethylindoles (e.g., pip-T, 5-MeO-pip-T, indoramin, indolylethylfentanyl)
- Pyrrolidinylethylindoles (e.g., pyr-T, 4-HO-pyr-T, 5-MeO-pyr-T, 4-F-5-MeO-pyr-T, L-760790)
- Pyrrolidinylmethylindoles (e.g., MPMI, 4-HO-MPMI (lucigenol), 5F-MPMI, 5-MeO-MPMI, CP-122288, CP-135807, eletriptan, MSP-2020)
- Tetrahydrocarbazolamines (e.g., ciclindole, flucindole, frovatriptan, LY-344864, ramatroban)
- Tetrahydropyridinylethylindoles (e.g., AHR-1709)
- Tetrahydropyridinylindoles (e.g., RS134-49, RU-28253, NEtPhOH-3-THPI)
- Tetrahydropyrroloquinolines (e.g., bufothionine, O-methylnordehydrobufotenine, dehydrobufotenine)
- Yohimbans (e.g., yohimbine, rauwolscine, spegatrine, corynanthine, ajmalicine, reserpine, deserpidine, rescinnamine)
- Z5247692566
- 5-MeO-isoDMT
- 6-MeO-isoDMT
- isoAMT (1-API; 1-IT; α-Me-isoT)
- isoDMT
- Isotryptamine (isoT)
- Ro60-0175
- VER-3323
- Zalsupindole (DLX-001, AAZ-A-154)
- Cyclized isotryptamines: DLX-0002700
- JRT
- PNU-181731
- 1-Methylmedmain
- 2-Azapsilocin
- 2,3-Dihydro-L-tryptophan
- 2,3-Dihydrotryptamine
- 2,3-Dihydro-DMT
- 2,3-Dihydro-NMT
- 2,3-Dihydro-DET
- 4-Aza-5-MeO-DPT
- 5-Aza-4-MeO-DiPT
- 5-HIAA
- 5-HIAL
- 5-HITCA
- 5-MIAL
- 7-Aza-5-MeO-DiPT
- α-Carboline
- γ-Carbolines (pyridoindoles) (e.g., γ-carboline, 2MePI, 8MeO-2MePI, alosetron, gevotroline, latrepirdine, lurosetron, mebhydrolin, tiflucarbine)
- Amedalin
- Benzindopyrine
- Benzydamine
- Benzofurans (e.g., 3-APB (1-oxa-AMT), 5-MeO-DiBF (1-oxa-5-MeO-DiPT), BPAP, 3-F-BPAP, dimemebfe (5-MeO-BFE; 1-oxa-5-MeO-DMT), mebfap (5-MeO-3-APB; 1-oxa-5-MeO-AMT), MiPBF (1-oxa-MiPT), oxa-noribogaine)
- Benzothiophenes (e.g., S-DMT (1-thia-DMT), 3-APBT (1-thia-AMT))
- BMS-505130
- Carmoxirole
- CT-4436
- Daledalin
- Gramine
- Histamine
- Homotryptamines (e.g., HT, DMHT)
- I-32
- IAL
- Indalpine
- Indazolethylamines (e.g., AL-34662, AL-38022A, O-methyl-AL-34662, VU6067416, YM-348)
- Indenylethylamines (e.g., C-DMT (1-carba-DMT))
- Indolizinylethylamines (e.g., TACT908 (2ZEDMA), 1ZP2MA, 1Z2MAP1O)
- Indolylaminopropanes (e.g., 1-API, 2-API, 4-API, 5-API (5-IT; PAL-571), 6-API (6-IT), 7-API)
- Iprindole
- Masupirdine
- Medmain
- Methylindolylethylpyridine (IN-399)
- Molindone
- Non-tryptamine triptans (e.g., avitriptan, LY-334370, naratriptan)
- Ondansetron
- Oxazinopyridoindoles (e.g., IHCH-8134)
- Phenethylamines (e.g., phenethylamine, amphetamine)
- Piperazinylbenzisothiazoles (e.g., lurasidone, perospirone, tiospirone, ziprasidone)
- Piperidinylbenzimidazolines (e.g., benperidol, timiperone)
- Piperidinylbenzisoxazoles (e.g., iloperidone, milsaperidone, ocaperidone, paliperidone, risperidone)
- Piperidinylindoles (e.g., BRL-54443, LY-334370, naratriptan, sertindole, SN-22)
- Pirlindole
- Pyridinylbenzimidazoles (e.g., droperidol)
- Pyridopyrroloquinoxalines (e.g., IHCH-7113, IHCH-7079, IHCH-7086, lumateperone, deulumateperone, ITI-1549)
- Pyrrolylethylamines (e.g., 2-pyrrolylethylamine (NEA), 3-pyrrolylethylamine (3-NEA), 3-pyrrolylpropylamine)
- Pyrrolopyridinylethylamines (e.g., WAY-208466)
- Quinolinylethylamines (e.g., mefloquine)
- Ro60-0213
- Roxindole (EMD-49980)
- Selisistat
- Tetrahydropyridinylindoles (e.g., EMD-386088, RU-24969 (5-MeO-THPI), MTHPI, 5-MeO-MTHPI, tepirindole, Lu 35-138, LY-367265)
- Tetrahydropyridinylpyrrolopyridines (e.g., (R)-69 (3IQ), (R)-70, CP-93129, CP-94253)
- Tetrindole
- Tipindole
- Zilpaterol (RU-42173)
Text derived from https://en.wikipedia.org/w/index.php?oldid=1363809128 under CC BY-SA 4.0; modifications have been made.